Larimar Therapeutics Inc
XNAS: LRMR
Larimar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-...
Read More
3.63
0.06
(1.68%)
50,303
XNAS Volume
XNAS 31 Jul, 2025 9:52 AM (EDT)
Board Meeting
The next board meeting for Larimar Therapeutics Inc is on 08 Aug 2025 for the purpose of Larimar Therapeutics Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Larimar Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..